Hodgkin's Lymphoma News

• 'Impressive' Antitumor Effects An experimental agent had 'impressive' results in metastatic, pretreated cancers, especially breast cancer, in a phase 1/2 study.
  Medscape Medical News, July 2019
• AstraZeneca-Daiichi Breast Cancer Treatment Shows Promise in Latest Study An experimental breast cancer drug being developed by British drugmaker AstraZeneca and Japan's Daiichi Sankyo's met its main goal in a mid-stage study, bolstering their position in a highly competitive oncology market.
  Reuters Health Information, May 2019
• Cemiplimab and Talazoparib Head Toward Approval in the EU Both drugs have received a positive opinion from the European Medicine Agency's Committee for Medicinal Products for Human Use, which is the first step in obtaining marketing approval in the European Union.
  International Approvals, April 2019
• Consensus Guidelines Target Maintenance Therapies for Lymphomas After Autologous Transplant Maintenance therapy guidelines for lymphoma patients who have undergone autologous hematopoietic cell transplantation (HCT) were recently released by an expert panel from the American Society for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation.
  Reuters Health Information, March 2019
• The 'London Patient' New HIV Remission Raises Hope HIV remission and cure are so rare as to be singularly notable. But is a new case of HIV remission replicable?
  Medscape Medical News, March 2019
• Study of AYA-Cancer Survivors Can Guide Surveillance for New Primary Neoplasms A new study breaks down the excess risk of new primary malignancies in survivors of adolescent and young adult (AYA) cancers by the type of the first cancer, helping to inform surveillance efforts.
  Reuters Health Information, February 2019
• Higher Risk of Lymphoma With Hidradenitis Suppurativa People with hidradenitis suppurativa face a lymphoma risk twice that of the general population, researchers report.
  Reuters Health Information, February 2019
• Risk for Suicide Spikes After Cancer Diagnosis Two new studies show that after a cancer diagnosis, the risk for suicide increases significantly and may be as much as four times higher than in the general population.
  Medscape Medical News, January 2019
• FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma With this approval, patients with advanced/metastatic MCC will now have another treatment option.
  Medscape Medical News, December 2018
• After 40 Years, 26% of Pediatric HL Survivors Have a Solid Tumor After pediatric Hodgkin lymphoma, the subsequent risk for a solid tumor goes on and on -- to 40 years and beyond.
  Medscape Medical News, December 2018
• Brentuximab Vedotin and Chemotherapy Effective in Peripheral T-cell Lymphoma Brentuximab vedotin (Adcetris, Seattle Genetics) in combination with chemotherapy is significantly more effective than chemotherapy alone in patients with CD30-positive peripheral T-cell lymphomas, according to the multinational phase 3 ECHELON-2 trial.
  Reuters Health Information, December 2018
• ASH 2018Four Cycles of CHOP Instead of Six for Favorable DLBCL Patients with favorable-prognosis DLBCL receiving four cycles of R-CHOP followed by two additional cycles of rituximab had outcomes similar to those in patients receiving six cycles.
  Medscape Medical News, December 2018
• Alert Approval in 2 Weeks via FDA's New Oncology Drugs Review Approval of a new indication took only 2 weeks with the FDA's new program for reviewing oncology drugs. It involved expanded use of the lymphoma drug brentuximab vedotin.
  FDA Approvals, November 2018
• States Act to Safeguard Young Cancer Patients' Chances to Have Children Some states now require health insurance plans to cover fertility preservation care when medically necessary treatment jeopardizes fertility.
  Kaiser Health News, October 2018
• Eating More Organic Food Tied to Lower Cancer Risk A huge observational study from France surveyed adults online about food consumption and then followed them for a mean of 5 years.
  Medscape Medical News, October 2018
• 'Unexpected': Age 35 Key to Ovarian Function After Chemo for HL Age impacts recovery of ovarian function after chemotherapy for Hodgkin's lymphoma, even when regimens considered less toxic are used.
  Medscape Medical News, October 2018
• Risk of Second Primary Cancer on the Rise in People With HIV
  Reuters Health Information, September 2018
• Czech Beer Is Designed for Cancer Patients' Tastes The nonalcoholic beer has fewer hops, which reduces bitterness, and is diluted with apple juice for sweetening. Clinicians in the Czech Republic, where beer is the national drink, are handing it out to breast cancer patients.
  Medscape Medical News, July 2018
• Young Cancer Survivors at Higher Risk for Endocrine Diseases Adolescent and young adult survivors are at highest risk for thyroid disease, testicular dysfunction, and diabetes. Authors of a large study call for better surveillance of this underserved group.
  Medscape Medical News, July 2018
• EHA 2018First-in-Class Drug Against CD79b Improves Survival in DLBCL The first-in-class antibody-drug conjugate polatuzumab vedotin significantly improved response and overall survival in relapsed or refractory diffuse large B-cell lymphoma.
  Medscape Medical News, June 2018